GeneYouIn is a winner of HealthKick 2017 Award in Digital Health

Thanks a lot to esteemed judges for the vote of confidence, and acknowledging the innovative technology GeneYouIn is bringing to market to enable Personalized Medicine.

Pharmacogenetics: the future of personalized medicine is here

A key limitation of the current “one-size-fits-all” method of prescribing medications is that it cannot predict how specific patients will react to medications. A patient’s inability to metabolize a drug can lead to adverse side effects, lack of therapeutic efficacy, increased burden of disease, and additional costs for healthcare payers.[1]

In fact, more than 90 per cent of North Americans carry at least one genetic variation affecting drug response. In an effort to improve drug safety, regulatory agencies place information on drug labels with reference to pharmacogenetic testing for more than 200 medications. Personalizing patients’ medications based on their genetic makeup can help optimize drug therapy outcomes and minimize adverse drug events.[2]

About GeneYouIn Inc. and Pillcheck?

A Canadian digital health company, GeneYouIn builds technology and service platforms to bring personalized medicine to healthcare. GeneYouIn’s flagship product, Pillcheck? is a medication optimization service aimed at making medications safer and more effective by providing personalized and actionable pharmacogenetic insights to individuals and their healthcare practitioners. Pillcheck? includes a state-of-the-art DNA testing technology to identify specific variations in genes responsible for drug absorption and metabolism and medication review with a specially trained pharmacist. For more information, visit pillcheck.ca.

[1] Genomics of Adverse Drug Reactions. Alfirevic A, Pirmohamed M.

Trends Pharmacol Sci. 2016 Dec 9. pii: S0165-6147(16)30161-4. doi: 10.1016/j.tips.2016.11.003. PMID: 27955861

[2] Pharmacogenomics in the clinic. Relling MV, Evans WE.

Nature. 2015 Oct 15;526(7573):343-50. doi: 10.1038/nature15817. Review.

PMID: 26469045 

Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings. Fagerness J, Fonseca E, Hess GP, Scott R, Gardner KR, Koffler M, Fava M, Perlis R, Brennan FX, Lombard J. Am J Manag Care. 2014 May;20(5):e146-56.

PMID: 25326929